[ASND] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
19-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 21.21%
YoY- -18.05%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 33,589 6,828 746 2,225 5,414 28 372 111.73%
PBT -109,617 -125,257 -62,983 -63,394 -53,707 -41,482 -25,153 27.79%
Tax 1,297 241 -191 -77 -70 -107 -14 -
NP -110,914 -125,498 -62,792 -63,317 -53,637 -41,375 -25,139 28.05%
Tax Rate - - - - - - - -
Total Cost 144,503 132,326 63,538 65,542 59,051 41,403 25,511 33.49%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -330.21 -1,837.99 -8,417.16 -2,845.71 -990.71 -147,767.86 -6,757.80 -39.52%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -1.98 -2.21 -1.17 -1.32 -1.24 -1.07 -0.78 16.78%
EPS Diluted -1.98 -2.21 -1.17 -1.32 -1.24 -1.07 -0.78 16.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.